Page last updated: 2024-08-17

aldosterone and relcovaptan

aldosterone has been researched along with relcovaptan in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brouard, R; DiBlasi, TP; Kilani, A; Leenhardt, AF; Rahman, M; Smith, MC; Thibonnier, M; Warner, K	1
Delarue, C; Do Rego, JL; Kuhn, JM; Lefebvre, H; Perraudin, V; Vaudry, H	1

Trials

2 trial(s) available for aldosterone and relcovaptan

Article	Year
Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:6 Topics: Administration, Oral; Adult; Aldosterone; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Black People; Blood Volume; Cross-Over Studies; Double-Blind Method; Heart Rate; Hormone Antagonists; Humans; Hypertension; Indoles; Kidney Function Tests; Male; Platelet Aggregation; Pyrrolidines; Renin; Serum Albumin; Sodium; Treatment Outcome; White People	1999
Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies. The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:4 Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Cross-Over Studies; Double-Blind Method; Female; Fluorescent Antibody Technique; Hormone Antagonists; Humans; Hyperaldosteronism; Immunohistochemistry; Indoles; Male; Middle Aged; Pituitary Neoplasms; Pyrrolidines; Receptors, Vasopressin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Vasopressins	2006

Article

Year

Effects of the nonpeptide V(1) vasopressin receptor antagonist SR49059 in hypertensive patients.

Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:6

Topics: Administration, Oral; Adult; Aldosterone; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Black People; Blood Volume; Cross-Over Studies; Double-Blind Method; Heart Rate; Hormone Antagonists; Humans; Hypertension; Indoles; Kidney Function Tests; Male; Platelet Aggregation; Pyrrolidines; Renin; Serum Albumin; Sodium; Treatment Outcome; White People

1999

Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies.

The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:4

Topics: Adenoma; Adrenocorticotropic Hormone; Aldosterone; Cross-Over Studies; Double-Blind Method; Female; Fluorescent Antibody Technique; Hormone Antagonists; Humans; Hyperaldosteronism; Immunohistochemistry; Indoles; Male; Middle Aged; Pituitary Neoplasms; Pyrrolidines; Receptors, Vasopressin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Vasopressins

2006